Literature DB >> 12952174

Amelogenin self-assembly and the role of the proline located within the carboxyl-teleopeptide.

Michael L Paine1, Hong-Jun Wang, Malcolm L Snead.   

Abstract

A hallmark of biological systems is a reliance on protein assemblies to perform complex functions. We have focused attention on mammalian enamel formation because it relies on a self-assembling protein complex to direct mineral habit. The principle protein of enamel is amelogenin that self-assembles to form nanospheres. In mice, the principal amelogenin product is a 180 amino acid hydrophobic protein. The yeast two-hybrid assay has been used to demonstrate the importance of amelogenin self-assembly domains. We have generated specific variants of amelogenin to analyze contributions of individual amino acids to the self-assembly process. These amelogenin variants have been produced either by deleting carboxyl-terminal amino acids (to generate proteins that relate to the documented proteolytic products of mouse amelogenin) or by a site-directed mutagenesis approach. Assessment of variant amelogenins truncated at the carboxyl-terminal imply that the proline at position 169 of mouse amelogenin (M180) plays a significant role in amelogenin self-assembly. Site-directed mutagenesis of this particular proline, however, failed to disrupt the amelogenin self-assembly property. These conflicting data add to the complexity of protein-protein assembly mechanisms as they relate to the enamel matrix. Available data suggest a robustness of this enamel protein (amelogenin) that ensures a functional, even though mechanically less than optimal, enamel results despite either minor or major genetic errors to the amelogenin gene locus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12952174

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  6 in total

1.  Molecular evolution of amelogenin in mammals.

Authors:  Sidney Delgado; Marc Girondot; Jean-Yves Sire
Journal:  J Mol Evol       Date:  2005-01       Impact factor: 2.395

2.  Determination of protein regions responsible for interactions of amelogenin with CD63 and LAMP1.

Authors:  YanMing Zou; HongJun Wang; Jason L Shapiro; Curtis T Okamoto; Steven J Brookes; S Petter Lyngstadaas; Malcolm L Snead; Michael L Paine
Journal:  Biochem J       Date:  2007-12-15       Impact factor: 3.857

3.  Leucine-rich amelogenin peptides regulate mineralization in vitro.

Authors:  E Le Norcy; S-Y Kwak; F B Wiedemann-Bidlack; E Beniash; Y Yamakoshi; J P Simmer; H C Margolis
Journal:  J Dent Res       Date:  2011-06-07       Impact factor: 6.116

4.  Potential role of the amelogenin N-terminus in the regulation of calcium phosphate formation in vitro.

Authors:  E Le Norcy; S-Y Kwak; F B Wiedemann-Bidlack; E Beniash; Y Yamakoshi; J P Simmer; H C Margolis
Journal:  Cells Tissues Organs       Date:  2011-05-13       Impact factor: 2.481

5.  Effect of phosphorylation on the interaction of calcium with leucine-rich amelogenin peptide.

Authors:  Elvire Le Norcy; Seo-Young Kwak; Marc Allaire; Peter Fratzl; Yasuo Yamakoshi; James P Simmer; Henry C Margolis
Journal:  Eur J Oral Sci       Date:  2011-12       Impact factor: 2.612

6.  Remineralization Efficacy of an Amelogenin-Based Synthetic Peptide on Carious Lesions.

Authors:  Jinpu Chu; Xiaofang Feng; Huijing Guo; Tieting Zhang; Hualei Zhao; Qun Zhang
Journal:  Front Physiol       Date:  2018-07-05       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.